SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Total Voting Rights

29 Mar 2019 09:01

RNS Number : 4642U
Accsys Technologies PLC
29 March 2019
 

 

29 March 2019

AIM: AXS

Euronext Amsterdam: AXS

 

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Total Voting Rights

 

Further to the recent announcement of the issue of 70,175 new ordinary shares of €0.05 each in the capital of the Company pursuant to the Employment Benefit Trust, and pursuant to 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following:

 

The issued share capital of the Company now consists of 117,988,305 ordinary shares of €0.05 each with voting rights. No ordinary shares are held in treasury.

 

The above figure of 117,988,305 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules. This figure replaces and supersedes any figure previously announced.

 

 

ACCSYS TECHNOLOGIES PLC ("Accsys" of "de Vennootschap")

 

Totaal aantal stemrechten

 

Naar aanleiding van de recente aankondiging van de uitgifte van 70,175 nieuwe gewone aandelen in het kapitaal van de Vennootschap van € 0,05 per aandeel op grond van de Employment Benefit Trust, en in naleving van 5.6.1 van de Disclosure and Transparency Rules, informeert de Vennootschap de markt over het volgende:

 

Het uitgegeven aandelenkapitaal van de Vennootschap bestaat thans uit 117.988.305 gewone stemgerechtigde aandelen van € 0,05 per aandeel. Er is geen sprake van ingekochte eigen aandelen.

 

Het is aandeelhouders toegestaan het bovengenoemde getal van 117.988.305 gewone aandelen te gebruiken als deler bij berekeningen voor het bepalen van de noodzaak om hun belang, of een verandering in hun belang, in de Vennootschap te melden onder de Disclosure and Transparency Rules van de FCA. Dit getal vervangt alle eerder aangekondigde getallen.

 

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

Hans Pauli, Executive Director, Corporate Development

via MHP Communications

Numis Securities

Nominated Adviser: Oliver Hardy

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

 

Off the Grid

(The Netherlands)

Frank Neervoort

Yvonne Derske

+31 681 734 236

+31 222 379 666

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a highly sustainable and environmentally responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of naturally occurring 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

Accsys Technologies is the trading name of Titan Wood Limited. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRPGURAWUPBURB
Date   Source Headline
17th Aug 20124:27 pmRNSAccsys Employee Share Participation Plan
9th Aug 20127:01 amRNSInterim Management Statement
3rd Aug 20127:02 amRNSEmployee Share Participation Plan and Grant of Opt
27th Jul 20124:30 pmRNSTotal Voting Rights
24th Jul 20127:02 amRNSHeads of Terms with INEOS for joint venture
13th Jul 20129:18 amRNSDirector/PDMR Shareholding
11th Jul 20124:40 pmRNSSecond Price Monitoring Extn
11th Jul 20124:35 pmRNSPrice Monitoring Extension
10th Jul 20127:00 amRNSAnnual Results
5th Jul 20124:16 pmRNSDirectors' Interests
5th Jul 20129:02 amRNSAnnual results release date and webcast
2nd Jul 20127:02 amRNSAccoya® Licence Agreement with Solvay-Rhodia
30th Apr 20127:04 amRNSLicence Option Agreeement
29th Mar 20124:49 pmRNSNotifiable Interest
15th Mar 20125:24 pmRNSDirector/PDMR Shareholding
6th Mar 201210:21 amRNSBP Strategic Relationship
22nd Feb 20122:10 pmRNSTotal Voting Rights
21st Feb 20123:38 pmRNSNotifiable Interest
17th Feb 20127:01 amRNSInterim Management Statement
10th Feb 20124:35 pmRNSPrice Monitoring Extension
7th Feb 20124:52 pmRNSDirector Shareholding
7th Feb 201210:41 amRNSNotifiable Interest
27th Jan 20129:46 amRNSAnnual Information Update
24th Jan 201210:11 amRNSNotifiable Interest
18th Jan 20124:40 pmRNSSecond Price Monitoring Extn
18th Jan 20124:35 pmRNSPrice Monitoring Extension
16th Jan 20124:40 pmRNSSecond Price Monitoring Extn
16th Jan 20124:35 pmRNSPrice Monitoring Extension
3rd Jan 20122:08 pmRNSDirector/PDMR Shareholding
30th Dec 201112:40 pmRNSSecond Price Monitoring Extn
30th Dec 201112:35 pmRNSPrice Monitoring Extension
20th Dec 20114:40 pmRNSDirector/PDMR Shareholding
16th Dec 20113:34 pmRNSNotifiable Interest
9th Dec 20114:35 pmRNSPrice Monitoring Extension
6th Dec 20119:24 amRNSNotifiable Interest
30th Nov 20117:12 amRNSSeptember 2011 Interim Financial Statement
25th Nov 201112:22 pmRNSInterim results release date and webcast
2nd Nov 20114:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20114:35 pmRNSPrice Monitoring Extension
21st Oct 20118:28 amRNSAppointment of Nominated Advisor and broker
8th Sep 20113:25 pmRNSResult of AGM
31st Aug 20119:05 amRNSTotal Voting Rights
10th Aug 20117:01 amRNSInterim Management Statement
4th Aug 20114:40 pmRNSSecond Price Monitoring Extn
4th Aug 20114:35 pmRNSPrice Monitoring Extension
1st Aug 201111:42 amRNSEmployee Share Plan and Grant of Options
20th Jul 20112:02 pmRNSNotice of Annual General Meeting
5th Jul 201111:52 amRNSChange of Registered Office
30th Jun 20117:00 amRNSAnnual Financial Report
28th Jun 20117:01 amRNSAnnual results release date and webcast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.